We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$515M
AUM Growth
-$30.1M
Cap. Flow
-$7.12M
Cap. Flow %
-1.38%
Top 10 Hldgs %
16.03%
Holding
304
New
12
Increased
100
Reduced
100
Closed
22

Top Buys

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$1.65M
2
ETN icon
Eaton
ETN
+$645K
3
OII icon
Oceaneering
OII
+$550K
4
CTSH icon
Cognizant
CTSH
+$485K
5
BPL
Buckeye Partners, L.P.
BPL
+$414K

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$1.19M
2
AME icon
Ametek
AME
+$1.17M
3
AMX icon
America Movil
AMX
+$674K
4
JPM icon
JPMorgan Chase
JPM
+$542K
5
C icon
Citigroup
C
+$501K

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Industrials 17.09%
3 Financials 8.7%
4 Healthcare 8.6%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRCL
176
DELISTED
Stericycle Inc
SRCL
$608K 0.12%
5,213
+359
+7% +$42.4K
EGY icon
177
Vaalco Energy
EGY
$564M
$601K 0.12%
70,666
-17,434
-20% -$141K
MRO
178
DELISTED
Marathon Oil Corporation
MRO
$600K 0.12%
15,950
– –
RPM icon
179
RPM International
RPM
$13B
$595K 0.12%
13,000
– –
SOHU
180
Sohu.com
SOHU
$346M
$590K 0.11%
11,743
+680
+6% +$38.4K
RAD
181
DELISTED
Rite Aid Corporation
RAD
$589K 0.11%
6,087
+1,552
+34% +$200K
ABBV icon
182
AbbVie
ABBV
$448B
$579K 0.11%
10,026
+100
+1% +$5.55K
RMD icon
183
ResMed
RMD
$28.8B
$564K 0.11%
11,457
– –
TRV icon
184
Travelers Companies
TRV
$78.4B
$564K 0.11%
6,001
– –
TCX icon
185
Tucows
TCX
$114M
$561K 0.11%
37,579
-9,328
-20% -$142K
CAT icon
186
Caterpillar
CAT
$398B
$556K 0.11%
5,615
– –
WMB icon
187
Williams Companies
WMB
$90.7B
$554K 0.11%
10,000
– –
MTZ icon
188
MasTec
MTZ
$26.6B
$553K 0.11%
18,076
+665
+4% +$19.8K
CPL
189
DELISTED
CPFL Energia S.A.
CPL
$552K 0.11%
37,518
+20,299
+118% +$346K
ROK icon
190
Rockwell Automation
ROK
$51B
$549K 0.11%
5,000
-104
-2% -$12.2K
NOV icon
191
NOV
NOV
$7.02B
$539K 0.1%
7,079
-370
-5% -$30.6K
EXC icon
192
Exelon
EXC
$47B
$535K 0.1%
22,007
+342
+2% +$8.01K
HUN icon
193
Huntsman Corp
HUN
$2.1B
$520K 0.1%
20,000
– –
OII icon
194
Oceaneering
OII
$4.27B
$519K 0.1%
+7,959
New +$550K
GHDX
195
DELISTED
Genomic Health, Inc.
GHDX
$502K 0.1%
17,737
-4,493
-20% -$125K
SYNT
196
DELISTED
Syntel Inc
SYNT
$493K 0.1%
11,212
-800
-7% -$35.2K
FLS icon
197
Flowserve
FLS
$8.53B
$492K 0.1%
6,972
-547
-7% -$40.5K
AET
198
DELISTED
Aetna Inc
AET
$486K 0.09%
6,000
– –
TDC icon
199
Teradata
TDC
$2.88B
$479K 0.09%
11,426
+822
+8% +$35.4K
BRK.B icon
200
Berkshire Hathaway Class B
BRK.B
$1.06T
$473K 0.09%
3,425
– –
6 7
8
9 10

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley-Laman Group held 304 positions worth $515M, down 5.5% from $545M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q3 2014 filing shows 12 new, 100 increased, 100 reduced and 22 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M. The largest sale was Trip.com Group, an estimated $1.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Stanley-Laman Group's largest Q3 2014 buy was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M.
  • Stanley-Laman Group added most to Eaton in Q3 2014, an estimated $645K increase.
  • Stanley-Laman Group's biggest Q3 2014 reduction was Trip.com Group, cutting an estimated $1.19M.
  • Stanley-Laman Group fully exited Ametek in Q3 2014, selling an estimated $1.17M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $515M portfolio in Q3 2014.
  • Stanley-Laman Group opened 12 new positions and closed 22 in Q3 2014.
  • Stanley-Laman Group's portfolio value fell 5.5% quarter-over-quarter to $515M.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.